ArticleFrontiers in cardiovascular medicine2026

SIMVASTATIN as a potential protective strategy against doxorubicin-induced cardiotoxicity.

Barbara Pala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.